摘要
目的:探讨应用依达拉奉联合参芎葡萄糖注射液治疗缺血性视神经病变的疗效。方法:将40例缺血性视神经病变患者随机分为对照组和治疗组,2组均给予激素、B族维生素药物等基础治疗,治疗组加用依达拉奉与参芎葡萄糖注射液,共14天,观察2组治疗前及治疗后神经功能缺损程度、临床疗效、视觉诱发电位指标变化。结果:治疗组患者神经功能恢复明显优于对照组。2组治疗后视神经功能评分、视觉诱发电位比较,差异有统计学意义(P<0.05)。结论:依达拉奉联合参芎葡萄糖注射液治疗缺血性视神经病变安全有效。
Objective： To investigate the Combined Chiefs of edaravone Xiong glucose injection in the treatment efficacy of ischemic optic neuropathy. Methods： 40 cases of ischemic optic neuropathy patients were randomly divided into control and treatment groups, two groups were given the hormone, B vitamins, drugs and other infrastructure, the treatment group and edaravone and Shenxiong glucose injection, a total of 14 d,were observed before treatment and after treatment, the degree of neurological deficits, clinical efficacy, visual evoked potential indicators of change.Results： Patients treated with recovery of neurological function than the control group. After treatment, optic nerve function score, visual evoked potentials, the difference was statistically significant （P 〈0.05）. Conclusions： The edaravone joint parameters the Gung glucose injection in the treatment of ischemic optic neuropathy is safe and effective.
出处
《中国伤残医学》
2012年第11期16-18,共3页
Chinese Journal of Trauma and Disability Medicine
关键词
依达拉奉
参芎葡萄糖
缺血性视神经病变
According to edaravone
Shenxiong to glucose
ischemic optic neuropathy
